Literature DB >> 18359209

Surveillance and treatment of malignancy in Bloom syndrome.

E R A Thomas1, S Shanley, L Walker, R Eeles.   

Abstract

We report a patient with Bloom syndrome, a rare autosomal recessive condition characterised by chromosomal instability leading to a high risk of cancer at an early age. The diagnosis should be considered in patients with any cancer of significantly early onset, short stature and a photosensitive lupus-like rash on the face. Diagnostic confirmation is obtained from chromosome studies that show significantly increased numbers of sister chromatid exchanges. There are important management implications, including minimising the use of ionising radiation in surveillance and treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18359209     DOI: 10.1016/j.clon.2008.01.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  8 in total

1.  Clinical and laboratory findings in 8 patients with Bloom's syndrome.

Authors:  Abderrahmen Masmoudi; Slaheddine Marrakchi; Hassen Kamoun; Hend Chaaben; Gada Ben Salah; Raida Ben Salah; Faiza Fakhfakh; Abdelmajid Zahaf; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2012-03-27

Review 2.  Immunogenetics of gastrointestinal cancers: A systematic review and retrospective survey of inborn errors of immunity in humans.

Authors:  Beishi Zheng; Michael G Artin; Howard Chung; Bing Chen; Siming Sun; Benjamin L May; Chin Hur; Peter H R Green; Timothy C Wang; Jiheum Park; Xiao-Fei Kong
Journal:  J Gastroenterol Hepatol       Date:  2022-04-13       Impact factor: 4.369

3.  Bloom's syndrome in an Indian man in the UK.

Authors:  Rajni Vekaria; Ree'Thee Bhatt; Ponnusamy Saravanan; Richard C de Boer
Journal:  BMJ Case Rep       Date:  2016-01-05

4.  A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype.

Authors:  Ingo Ruczinski; Timothy J Jorgensen; Yin Yao Shugart; Yvette Berthier Schaad; Bailey Kessing; Judith Hoffman-Bolton; Kathy J Helzlsouer; W H Linda Kao; Lee Wheless; Lesley Francis; Rhoda M Alani; Paul T Strickland; Michael W Smith; Anthony J Alberg
Journal:  Carcinogenesis       Date:  2012-05-11       Impact factor: 4.944

5.  Multidisciplinary management of endocrinopathies and treatment-related toxicities in patients with Bloom syndrome and cancer.

Authors:  Carolyn Fein Levy; Lubaina S Presswala; Alana Slomovic; Jessica Stiefel; Rifka Schulman-Rosenbaum
Journal:  Pediatr Blood Cancer       Date:  2020-11-23       Impact factor: 3.838

6.  Adenocarcinoma of the Right Colon in a Patient with Bloom Syndrome.

Authors:  Carlos Augusto Real Martinez; Lilian Vital Pinheiro; Debora Helena Rossi; Michel Gardere Camargo; Maria de Lourdes Setsuko Ayrizono; Raquel Franco Leal; Cláudio Saddy Rodrigues Coy
Journal:  Case Rep Surg       Date:  2016-08-15

7.  Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.

Authors:  Nils W Engel; Simon Schliffke; Ulrich Schüller; Christian Frenzel; Carsten Bokemeyer; Christian Kubisch; Davor Lessel
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

Review 8.  Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders.

Authors:  Jennie Vagher; Amanda Gammon; Wendy Kohlmann; Joanne Jeter
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.